Skip to main content
Erschienen in: Pediatric Surgery International 2/2007

01.02.2007 | Original Article

Histological response to injected dextranomer-based implant in a rat model

verfasst von: Murat Alkan, Arbay O. Ciftci, Beril Talim, Mehmet E. Senocak, Melda Caglar, Nebil Buyukpamukcu

Erschienen in: Pediatric Surgery International | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

To investigate the short and long term histopathological alterations caused by submucosal injection of dextranomers in sodium hyaluronan (DiHA) based on an experimental rat model. Sixty Sprague–Dawley rats were assigned into two groups as group I and II, each containing 30 rats. Totally 0.1 ml of saline solution and 0.1 ml of DiHA were injected into the submucosa of bladder of first (control) and second groups, respectively. Both group I and II were further subdivided into three other groups as Group IA, IB, IC and Group IIA, IIB, IIC according to the sacrificial period. Group IA and IIA, IB and IIB, IC and IIC rats (ten rats for each group) were sacrificed 3, 6, and 12 months after surgical procedure, respectively. Two slides prepared from injection site of the bladder were evaluated completely for each rat by being unaware of the groups and at random by two independent senior pathologists to determine the fibroblast invasion, collagen formation, capillary growth and inflammatory reaction. Additionally, randomized brain sections from each rat were also examined to detect migration of the injection material. The measurements were made using an ocular micrometer at 10× magnification. The results were assessed using t-tests for paired and independent samples, with < 0.05 considered to indicate significant differences; all values were presented as the mean (SD). Migration to the brain was not detected in any group. Significant histopathological changes in the DiHA injected groups were granuloma formation in 43.3%, foreign body type giant cells in 76.6%, inflammatory infiltration in 100%, and fibroblasts surrounding microspheres in 100% of the rat bladder. The interaction between granuloma formation and long-term tissue effects in children is still obscure. We emphasize that further prospective human (and/or animal) studies are required to clarify the long-term effects of granuloma formation with regard to clinical applications.
Literatur
1.
Zurück zum Zitat O’Donnell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux. Br J Urol 58:601–604PubMed O’Donnell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux. Br J Urol 58:601–604PubMed
2.
Zurück zum Zitat Frey P, Jenny P, Herzog B (1991) Endoscopic subureteric collagen injection (SCIN): A new alternative treatment of vesicoureteric reflux in children. Experience in 82 refluxing ureters. Pediatr Surg Int 6:287–294 Frey P, Jenny P, Herzog B (1991) Endoscopic subureteric collagen injection (SCIN): A new alternative treatment of vesicoureteric reflux in children. Experience in 82 refluxing ureters. Pediatr Surg Int 6:287–294
3.
Zurück zum Zitat Lipsky H (1991) Endoscopic treatment of vesicouretic reflux with collagen. Pediatr Surg Int 6:301–303CrossRef Lipsky H (1991) Endoscopic treatment of vesicouretic reflux with collagen. Pediatr Surg Int 6:301–303CrossRef
4.
Zurück zum Zitat Frey P, Berger D, Jenny P, Herzog B (1992) Subureteral collagen injection for the endoscopic treatment of vesicoureteral reflux in children. Follow up study of 97 treated ureters and histological analysis of collagen implants. J Urol 148:718–723PubMed Frey P, Berger D, Jenny P, Herzog B (1992) Subureteral collagen injection for the endoscopic treatment of vesicoureteral reflux in children. Follow up study of 97 treated ureters and histological analysis of collagen implants. J Urol 148:718–723PubMed
5.
Zurück zum Zitat Vereecken RL, Proesmans W (1995) Results of endoscopic treatment for vesico-ureteric reflux. Eur Urol 27(1):76–79PubMed Vereecken RL, Proesmans W (1995) Results of endoscopic treatment for vesico-ureteric reflux. Eur Urol 27(1):76–79PubMed
6.
Zurück zum Zitat Stenberg A, Lackgren G (1995) A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 154:800–803PubMedCrossRef Stenberg A, Lackgren G (1995) A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 154:800–803PubMedCrossRef
7.
Zurück zum Zitat Reunanen M (1995) Correction of vesicoureteral reflux in children by endoscopic collagen injection: a prospective study. J Urol 154(6):2156–2158PubMedCrossRef Reunanen M (1995) Correction of vesicoureteral reflux in children by endoscopic collagen injection: a prospective study. J Urol 154(6):2156–2158PubMedCrossRef
8.
Zurück zum Zitat Frey P, Lutz N, Jenny P, Herzog B (1995) Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children. J Urol 154(2 Pt 2):804–807PubMed Frey P, Lutz N, Jenny P, Herzog B (1995) Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children. J Urol 154(2 Pt 2):804–807PubMed
9.
Zurück zum Zitat Frey P, Gudinchet F, Jenny P (1997) Gax 65: a new injectable cross-linked collagen for the endoscopic treatment of vesicoureteral reflux a—double blind study evaluating its efficiency in children. J Urol 158(3):1210–1212PubMedCrossRef Frey P, Gudinchet F, Jenny P (1997) Gax 65: a new injectable cross-linked collagen for the endoscopic treatment of vesicoureteral reflux a—double blind study evaluating its efficiency in children. J Urol 158(3):1210–1212PubMedCrossRef
10.
Zurück zum Zitat Ortenberg J (1998) Endoscopic treatment of vesicoureteral reflux in children. Urol Clin North Am 25(1):151–156PubMedCrossRef Ortenberg J (1998) Endoscopic treatment of vesicoureteral reflux in children. Urol Clin North Am 25(1):151–156PubMedCrossRef
11.
Zurück zum Zitat Lackgren G, Wahlin N, Stenberg A (1999) Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr Suppl 431:62–71CrossRef Lackgren G, Wahlin N, Stenberg A (1999) Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr Suppl 431:62–71CrossRef
12.
Zurück zum Zitat Capozza N, Patricolo M, Lais A, Matarazzo E, Cainone P (2001) Endoscopic treatment of vesicoureteral reflux: twelve years’ experience. Urol Int 67(3):228–231PubMedCrossRef Capozza N, Patricolo M, Lais A, Matarazzo E, Cainone P (2001) Endoscopic treatment of vesicoureteral reflux: twelve years’ experience. Urol Int 67(3):228–231PubMedCrossRef
13.
Zurück zum Zitat Herz D, Hafez A, Baglı D, Capolicchio G, McLorie G, Khoury A (2001) Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: a North American clinical report. J Urol 166(5):1880–1886PubMedCrossRef Herz D, Hafez A, Baglı D, Capolicchio G, McLorie G, Khoury A (2001) Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: a North American clinical report. J Urol 166(5):1880–1886PubMedCrossRef
14.
Zurück zum Zitat Lackgren G, Wahlin N, Skoldenberg E, Stenberg A (2001) Long-term follow up of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166(5):1887–1892PubMedCrossRef Lackgren G, Wahlin N, Skoldenberg E, Stenberg A (2001) Long-term follow up of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166(5):1887–1892PubMedCrossRef
15.
Zurück zum Zitat Chertin B, Colhoun E, Velayudham M, Puri P (2002) Endoscopic treatment of vesicoureteral reflux: 11–17 years of follow up. J Urol 167:1443–1446PubMedCrossRef Chertin B, Colhoun E, Velayudham M, Puri P (2002) Endoscopic treatment of vesicoureteral reflux: 11–17 years of follow up. J Urol 167:1443–1446PubMedCrossRef
16.
Zurück zum Zitat Al-Hunayan AA, Kehinde EO, Elsalam MA, Al-Mukhtar RS (2002) Outcome of endoscopic treatment for vesicoureteral reflux in children using polydimehysiloxane. J Urol 168:2181–2183PubMedCrossRef Al-Hunayan AA, Kehinde EO, Elsalam MA, Al-Mukhtar RS (2002) Outcome of endoscopic treatment for vesicoureteral reflux in children using polydimehysiloxane. J Urol 168:2181–2183PubMedCrossRef
17.
Zurück zum Zitat Chertin B, De Caluwe D, Puri P (2003) Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene. J Urol 169(5):1847–1849PubMedCrossRef Chertin B, De Caluwe D, Puri P (2003) Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene. J Urol 169(5):1847–1849PubMedCrossRef
18.
Zurück zum Zitat Kirsch AJ, Perez-Brayfield MR, Scherz HC (2003) Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the children’s hospitals of Atlanta experience. J Urol 170(1):211–215PubMedCrossRef Kirsch AJ, Perez-Brayfield MR, Scherz HC (2003) Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the children’s hospitals of Atlanta experience. J Urol 170(1):211–215PubMedCrossRef
19.
Zurück zum Zitat Puri P, Chertin B, Velayudham M, Dass L, Colhoun E (2003) Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 170(4, Part 2 of 2):1541–1544PubMedCrossRef Puri P, Chertin B, Velayudham M, Dass L, Colhoun E (2003) Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 170(4, Part 2 of 2):1541–1544PubMedCrossRef
20.
Zurück zum Zitat Matouschek E (1981) Die Behandlung des vesikorenalen refluxes durch transurethrale Einspritzung von teflonpaste. Der Urologe Ausg A 20:263–264PubMed Matouschek E (1981) Die Behandlung des vesikorenalen refluxes durch transurethrale Einspritzung von teflonpaste. Der Urologe Ausg A 20:263–264PubMed
21.
Zurück zum Zitat Mittleman RE, Marraccini JV (1983) Pulmonary teflon granulomas following periurethral teflon injection for urinary incontinence. Arch Pathol Lab Med 107:611–612PubMed Mittleman RE, Marraccini JV (1983) Pulmonary teflon granulomas following periurethral teflon injection for urinary incontinence. Arch Pathol Lab Med 107:611–612PubMed
22.
Zurück zum Zitat Malizia AA Jr, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC Jr. Dewanjee MK, Utz WJ (1984) Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251:3277–3281PubMedCrossRef Malizia AA Jr, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC Jr. Dewanjee MK, Utz WJ (1984) Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251:3277–3281PubMedCrossRef
23.
Zurück zum Zitat Aaronson IA, Rames RA, Greene WB, Walsh LG, Hasal UA, Garen PD (1993) Endoscopic treatment of reflux: migration of teflon to the lungs and brain. Eur Urol 23:394–399PubMed Aaronson IA, Rames RA, Greene WB, Walsh LG, Hasal UA, Garen PD (1993) Endoscopic treatment of reflux: migration of teflon to the lungs and brain. Eur Urol 23:394–399PubMed
24.
Zurück zum Zitat Smith DP, Kaplan WE, Oyasu R (1994) Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 152: 1221–1224PubMed Smith DP, Kaplan WE, Oyasu R (1994) Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 152: 1221–1224PubMed
25.
Zurück zum Zitat Travis WD, Balogh K, Abraham JL (1985) Silicone granulomas: report of three cases and review of the literature. Hum Pathol 16:19–27PubMed Travis WD, Balogh K, Abraham JL (1985) Silicone granulomas: report of three cases and review of the literature. Hum Pathol 16:19–27PubMed
26.
Zurück zum Zitat Hatanaka S, Oneda S, Okazaki K, Shong LJ, Yoshida A, Isaka H, Yoshida H (1993) Induction of malignant fibrous histiocytoma in female Fisher rats by implantation of cyanoacrylate, zirconia; polyvinyl chloride, or silicone. In Vivo 7:111–115PubMed Hatanaka S, Oneda S, Okazaki K, Shong LJ, Yoshida A, Isaka H, Yoshida H (1993) Induction of malignant fibrous histiocytoma in female Fisher rats by implantation of cyanoacrylate, zirconia; polyvinyl chloride, or silicone. In Vivo 7:111–115PubMed
27.
Zurück zum Zitat Dewan PA, Byard RW (1992) Is injected polytetrafluoroethylene (polytef) carcinogenic? Br J Urol 69:29–33PubMedCrossRef Dewan PA, Byard RW (1992) Is injected polytetrafluoroethylene (polytef) carcinogenic? Br J Urol 69:29–33PubMedCrossRef
28.
Zurück zum Zitat Frey P, Lutz N, Berger D, Herzog B (1994) Histological behaviour of gluteraldehyde cross-linked bovine collagen injected into the human bladder for the treatment of vesicoureteral reflux. J Urol 152:632–635PubMed Frey P, Lutz N, Berger D, Herzog B (1994) Histological behaviour of gluteraldehyde cross-linked bovine collagen injected into the human bladder for the treatment of vesicoureteral reflux. J Urol 152:632–635PubMed
29.
Zurück zum Zitat Leonard MP, Canning DA, Epstein JI, Gearhart JP, Jeffs RD (1990) Local tissue reaction to the subureteral injection of glutaraldehyde cross-linked bovine collagen in humans. J Urol 143:1209–1212PubMed Leonard MP, Canning DA, Epstein JI, Gearhart JP, Jeffs RD (1990) Local tissue reaction to the subureteral injection of glutaraldehyde cross-linked bovine collagen in humans. J Urol 143:1209–1212PubMed
30.
Zurück zum Zitat Frey P, Curschellas E, Kaeslin M (1991) Long-term histological results following glutaraldehyde cross-linked collagen injection into the suburothelial space of the mini-pig bladder. Pediatr Surg Int 6:252–260 Frey P, Curschellas E, Kaeslin M (1991) Long-term histological results following glutaraldehyde cross-linked collagen injection into the suburothelial space of the mini-pig bladder. Pediatr Surg Int 6:252–260
31.
Zurück zum Zitat Kempter F, Möhring K, Bersch W (1991) Results of endoscopic subureteral collagen injection for reflux correction in pigs and dogs. Pediatr Surg Int 6:261–268CrossRef Kempter F, Möhring K, Bersch W (1991) Results of endoscopic subureteral collagen injection for reflux correction in pigs and dogs. Pediatr Surg Int 6:261–268CrossRef
32.
Zurück zum Zitat Ringert RH, Mlynek ML, Zöllner G (1991) Reaction to intramural collagen implantation in rabbit bladder. Pediatr Surg Int 6:263–265CrossRef Ringert RH, Mlynek ML, Zöllner G (1991) Reaction to intramural collagen implantation in rabbit bladder. Pediatr Surg Int 6:263–265CrossRef
33.
Zurück zum Zitat Vandenbossche M, Delhove O, Dumortier P (1993) Endoscopic treatment of reflux: Experimental study and review of teflon and collagen. Eur Urol 23:386–393PubMed Vandenbossche M, Delhove O, Dumortier P (1993) Endoscopic treatment of reflux: Experimental study and review of teflon and collagen. Eur Urol 23:386–393PubMed
34.
Zurück zum Zitat Frey P, Mangold S (1995) Physical and histological behavior of a new injectable collagen (Gax 65) implanted into submucosal space of the mini-pig bladder. J Urol 154(2):812–815PubMedCrossRef Frey P, Mangold S (1995) Physical and histological behavior of a new injectable collagen (Gax 65) implanted into submucosal space of the mini-pig bladder. J Urol 154(2):812–815PubMedCrossRef
35.
Zurück zum Zitat Stenberg A, Larsson E, Lackgren G (2003) Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 169(3):1109–1113PubMedCrossRef Stenberg A, Larsson E, Lackgren G (2003) Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 169(3):1109–1113PubMedCrossRef
36.
Zurück zum Zitat Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of a 125Iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158:1937–1941PubMedCrossRef Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of a 125Iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158:1937–1941PubMedCrossRef
37.
Zurück zum Zitat Stenberg A, Larsson E, Lindholm A, Ronneus B, Stenberg A, Lackgren G (1999) Injectable Dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 33:355–361PubMedCrossRef Stenberg A, Larsson E, Lindholm A, Ronneus B, Stenberg A, Lackgren G (1999) Injectable Dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 33:355–361PubMedCrossRef
Metadaten
Titel
Histological response to injected dextranomer-based implant in a rat model
verfasst von
Murat Alkan
Arbay O. Ciftci
Beril Talim
Mehmet E. Senocak
Melda Caglar
Nebil Buyukpamukcu
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 2/2007
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-006-1818-1

Weitere Artikel der Ausgabe 2/2007

Pediatric Surgery International 2/2007 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.